UK Primary Care Pilots PrecivityAD2 Blood Test for Alzheimer’s
Researchers at Imperial College London are integrating the PrecivityAD2 blood test from C2N Diagnostics into primary care pathways to accelerate Alzheimer’s disease diagnoses, according to a university release. Launched in May as part of the Davos Alzheimer’s Collaborative Healthcare System Preparedness program, the BEAD-PC study evaluates patients aged 50 and older showing signs of mild … Read more
